Zhongchao (ZCMD)

The company is best known for its MDMOOC platform, which provides medical education and training content for physicians, pharmacists, nurses, and other healthcare professionals. These services help pharmaceutical companies, medical institutions, and non-profit organisations communicate clinical knowledge, disease awareness, and treatment-related information to professional audiences in China.

Zhongchao also offers patient-focused digital services through systems and WeChat mini programs, including Zhongxun and Zhongxin Health. These tools are designed to support patient education, follow-up, disease management, and engagement between patients, healthcare providers, and healthcare industry sponsors. The model places the company at the intersection of digital health, medical communications, and pharmaceutical services.

As a listed company, Zhongchao gives investors exposure to a niche part of China’s healthcare internet market, where demand is influenced by pharmaceutical marketing budgets, regulatory requirements, medical education needs, and the adoption of digital tools in patient care. Its scale and prospects depend on its ability to maintain relationships with pharmaceutical enterprises, healthcare professionals, and institutional clients while operating within China’s evolving healthcare and data-governance environment.